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Chronic Severe Mitral RegurgitationWe read with interest the letter by Drs. Raﬁque and
Siegel, and thank them for their comments. In our
subpopulation of surgical patients, they show if one
uses the additional criterion of a left ventricular end-
diastolic dimension (LVEDD) $55 mm, concordance
between echocardiography and magnetic resonance
imaging (MRI) improves from 32% to 58%. They
conclude LVEDD should be a key parameter in the
echocardiographic assessment of chronic mitral
regurgitation (MR).
It is well accepted that chronic MR causes an in-
crease in LV size. We previously used this important
relationship to validate the accuracy of MRI for quan-
tifying regurgitant volume (1). We showed a tight
coupling between MR regurgitant volume and LV end-
diastolic volume (r2 ¼ 0.8), but this study was limited
to patients with isolated, primary MR.
Using LV size as an additional criterion may
improve the accuracy of echocardiography in a pop-
ulation of patients, but it is no substitute for the ac-
curate determination of MR severity in an individual
patient. This is because many other common diseases
and conditions affect LV size. Myocardial infarction,
nonischemic cardiomyopathy, and athletic heart can
substantially increase LV size without increasing MR.
Similarly, diseases such as restrictive cardiomyopa-
thy and aortic stenosis can substantially decrease LV
size without decreasing MR. Table 4 shows the limi-
tations of using LVEDD as a criterion for MR severity
(2). For example, patient #29 had an LVEDD of 62 mm,
yet had mild MR, and patient #38 had an LVEDD of
53 mm, yet had severe MR.
Using LV size as a surrogate to avoid overestimation
of MR severity is similar to the strategy advocated by
some, to delay surgery until patients are symptomatic.
The thought being that the presence of symptoms
avoids the possibility of inappropriate surgery in MR
patients that are mistakenly graded as severe (3).
However, as is the case with using any surrogate, a
potential problem is the possibility of confounding
illnesses, especially when they are common. Consider2 relatively common conditions: mild MR and restric-
tive cardiomyopathy. A patient with symptomatic
restrictive cardiomyopathy and mild MR that is
mistakenly graded as severe by echocardiography is at
high risk of undergoing inappropriate surgery.
In summary, we believe echocardiographers should
use all information available to them, including LV
size, to determine MR severity. However, given the
potential inaccuracy of echocardiography, and the cost
and complications of open heart surgery, we are
steadfast in our conclusion that cardiac MRI should be
a strong consideration when important clinical de-
cisions are being made based on MR severity, even in
the presence of symptoms.Seth Uretsky, MD
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Aortic StiffnessComplex Evaluation But Major
Prognostic Signiﬁcance Before TAVRWe read with great interest the paper by Yotti et al.
(1) regarding vascular load and transcatheter aortic
valve replacement (TAVR). This study underlines the
interaction between valvular and vascular functions
in patients with aortic stenosis (AS). The authors
highlighted the increase of vascular load after TAVR,
which limits the afterload relief acutely and may
endanger the cardiovascular prognosis later on.
Although no outcome data were available in this
study, we recently conﬁrmed this prognostic impact
by assessing the signiﬁcance of ascending aortic cal-
ciﬁcations (AAC)—a surrogate of stiffness measured
